Evaluation of the prevalence and prospective clinical impact of the <i>JAK2 V617F</i> mutation in coronary patients

Axel Muendlein(Vorarlberg Institute for Vascular Investigation and Treatment), Alois Lang(Landeskrankenhaus Feldkirch)
American Journal of Hematology
November 22, 2013
Cited by 20


Related Papers